Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2022 Volume 23 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes

  • Authors:
    • Ionela Mihaela Vladu
    • Maria Forțofoiu
    • Diana Clenciu
    • Mircea-Cătălin Forțofoiu
    • Rodica Pădureanu
    • Lucrețiu Radu
    • Ștefăniță Tiberiu Țenea Cojan
    • Patricia Mihaela Rădulescu
    • Vlad Pădureanu
  • View Affiliations / Copyright

    Affiliations: Department of Diabetes, Nutrition and Metabolic Diseases, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Emergency, Emergency Clinical County Hospital of Craiova, 200349 Craiova, Romania, Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Internal Medicine, Emergency Clinical County Hospital of Craiova, 200642 Craiova, Romania, Department of Hygiene, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania, Department of Pneumology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
    Copyright: © Vladu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 73
    |
    Published online on: November 24, 2021
       https://doi.org/10.3892/etm.2021.10996
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cardiovascular disease (CVD) is recognized as a leading cause of death worldwide. Obesity, dyslipidemia, insulin resistance (IR), interconnected pathological conditions constitute risk factors that are closely associated with CVD. The aim of the present study was to highlight the association of IR with cardiovascular risk (CVR). The epidemiological, cross‑sectional, non‑interventional study was conducted over 12 months (2019‑2020) within a research grant and included a sample of 400 subjects divided into 2 subgroups: group 1 (control) subjects did not have diabetes (n=200) and group 2 had type 2 diabetes (T2DM) (n=200). The Framingham risk score (FRS) was calculated according to the 2008 general CVD risk model from the Framingham Heart Study. Subsequent to a correlation of the value of homeostasis model assessment of insulin resistance (HOMA‑IR) with the degree of CVR, the IR was higher in both groups, and CVR also increased. After being quantified by the Spearman correlation coefficient, the correlation in group 2 was higher at 0.625 compared to group 1 where this coefficient had a value of 0.440. A high FRS (FRS of 20%) was significantly associated with IR. The results therefore show that HOMA‑IR is an independent risk factor for high FRS. New therapies focused on decreasing IR may contribute to decreased CVD.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A and Carmena R: Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 26:3320–3325. 2003.PubMed/NCBI View Article : Google Scholar

2 

Grigorescu ED, Lăcătușu CM, Crețu I, Floria M, Onofriescu A, Ceasovschih A, Mihai BM and Șorodoc L: Self-reported satisfaction to treatment, quality of life and general health of type 2 diabetes patients with inadequate glycemic control from north-eastern Romania. Int J Environ Res Public Health. 18(3249)2021.PubMed/NCBI View Article : Google Scholar

3 

Van Gaal LF, Mertens IL and De Block CE: Mechanisms linking obesity with cardiovascular disease. Nature. 444:875–880. 2006.PubMed/NCBI View Article : Google Scholar

4 

Adiels M, Olofsson SO, Taskinen MR and Borén J: Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 28:1225–1236. 2008.PubMed/NCBI View Article : Google Scholar

5 

Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA and Kahn CR: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 6:87–97. 2000.PubMed/NCBI

6 

Borén J, Taskinen M-R, Olofsson S-O and Levin M: Ectopic lipid storage and insulin resistance: A harmful relationship. J Intern Med. 274:25–40. 2013.PubMed/NCBI View Article : Google Scholar

7 

Ginsberg HN: Insulin resistance and cardiovascular disease. J Clin Invest. 106:453–458. 2000.PubMed/NCBI View Article : Google Scholar

8 

Reaven GM: Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab. 88:2399–2403. 2003.PubMed/NCBI View Article : Google Scholar

9 

Ashcroft FM and Rorsman P: Diabetes mellitus and the β cell: The last ten years. Cell. 148:1160–1171. 2012.PubMed/NCBI View Article : Google Scholar

10 

DeFronzo RA and Tripathy D: Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 32 (Suppl):S157–S163. 2009.PubMed/NCBI View Article : Google Scholar

11 

Ferrannini E and Cushman WC: Diabetes and hypertension: The bad companions. Hypertension. 380:601–610. 2012.PubMed/NCBI View Article : Google Scholar

12 

Steinberg HO, Brechtel G, Johnson A, Fineberg N and Baron AD: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest. 94:1172–1179. 1994.PubMed/NCBI View Article : Google Scholar

13 

Clenciu D, TeneaCojan TS, Dijmarescu A, Ene CG, Davitoiu DV, Baleanu VD, Ciora CA, Socea B, Voiculescu D, NedelcuŢă RM, et al: Diabetic retinopathy in relation with eGDR value in patients with type 1 diabetes mellitus. Rev Chim (Bucharest). 70:1434–1438. 2019.

14 

Laakso M: Heart in diabetes: A microvascular disease. Diabetes Care. 34 (Suppl):S145–S149. 2011.PubMed/NCBI View Article : Google Scholar

15 

The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 32:1327–1334. 2009.PubMed/NCBI View Article : Google Scholar

16 

Socea B, Radu L, Clenciu D, TeneaCojan TS, Baleanu VD, Ene CG, Girgavu SR and Vladu IM: The utility of visceral adiposity index in prediction of metabolic syndrome and hypercholesterolemia. RevChim (Bucharest). 69:3112–3114. 2018.

17 

Vladu IM, Radu L, Girgavu SR, Baleanu V, Clenciu D, Ene CG, Socea B, Mazen E, Cristea OM, Mota M, et al: An easy way to detect cardiovascular risk. Rev Chim (Bucharest). 69:3229–3232. 2018.

18 

American Diabetes Association: 2. Classification and diagnosis of diabetes. Standards of medical care in diabetes-2021. Diabetes Care. 44 (Suppl):S15–S33. 2021.

19 

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412–419. 1985.PubMed/NCBI View Article : Google Scholar

20 

D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro J and Kannel WB: General cardiovascular risk profile for use in primary care: The Framingham heart study. Circulation. 117:743–753. 2008.PubMed/NCBI View Article : Google Scholar

21 

Hernandez-Rodas MC, Valenzuela R and Videla LA: Relevant aspects of nutritional and dietary interventions in non-alcoholic fatty liver disease. Int J Mol Sci. 16:25168–25198. 2015.PubMed/NCBI View Article : Google Scholar

22 

Forțofoiu MC, Popescu DM, Pădureanu V, Dobrinescu AC, Dobrinescu AG, Mită A, Foarfă MC, Bălă VS, Muşetescu AE, Ionovici N and ForŢofoiu M: Difficulty in positive diagnosis of ascites and in differential diagnosis of a pulmonary tumor. Rom J Morphol Embryol. 58:1057–1064. 2017.PubMed/NCBI

23 

Valenzuela R and Videla LA: The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct. 2:644–648. 2011.PubMed/NCBI View Article : Google Scholar

24 

Grigorescu ED, Sorodoc V, Floria M, Anisie E, Popa AD, Onofriescu A, Ceasovschih A and Sorodoc L: The inflammatory marker hsCRP as a predictor of increased insulin resistance in type 2 diabetics without atherosclerotic manifestations. Rev Chim (Bucharest). 70:1791–1794. 2019.

25 

Forţofoiu M, Forţofoiu MC, Comănescu V, Dobrinescu AC, Pădureanu V, Vere CC, Streba CT and Ciurea PL: Hepatocellular carcinoma and metabolic diseases-histological perspectives from a series of 14 cases. Rom J Morphol Embryol. 56:1461–1465. 2015.PubMed/NCBI

26 

Mihailovici AR, Padureanu V, Albu CV, Dinescu VC, Pirlog MC, Dinescu SN, Malin RD and Calborean V: Myocardial Noncompaction. Rev Chim (Bucharest). 69:2209–2212. 2018.

27 

Vladu M, Clenciu D, Efrem IC, Forţofoiu MC, Amzolini A, Micu ST, Mota M and Fortofoiu M: Insulin resistance and chronic kidney disease in patients with type 1 diabetes mellitus. J Nutr Metab. 2017(6425359)2017.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Vladu IM, Forțofoiu M, Clenciu D, Forțofoiu M, Pădureanu R, Radu L, Cojan ȘT, Rădulescu PM and Pădureanu V: Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes. Exp Ther Med 23: 73, 2022.
APA
Vladu, I.M., Forțofoiu, M., Clenciu, D., Forțofoiu, M., Pădureanu, R., Radu, L. ... Pădureanu, V. (2022). Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes. Experimental and Therapeutic Medicine, 23, 73. https://doi.org/10.3892/etm.2021.10996
MLA
Vladu, I. M., Forțofoiu, M., Clenciu, D., Forțofoiu, M., Pădureanu, R., Radu, L., Cojan, Ș. T., Rădulescu, P. M., Pădureanu, V."Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes". Experimental and Therapeutic Medicine 23.1 (2022): 73.
Chicago
Vladu, I. M., Forțofoiu, M., Clenciu, D., Forțofoiu, M., Pădureanu, R., Radu, L., Cojan, Ș. T., Rădulescu, P. M., Pădureanu, V."Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes". Experimental and Therapeutic Medicine 23, no. 1 (2022): 73. https://doi.org/10.3892/etm.2021.10996
Copy and paste a formatted citation
x
Spandidos Publications style
Vladu IM, Forțofoiu M, Clenciu D, Forțofoiu M, Pădureanu R, Radu L, Cojan ȘT, Rădulescu PM and Pădureanu V: Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes. Exp Ther Med 23: 73, 2022.
APA
Vladu, I.M., Forțofoiu, M., Clenciu, D., Forțofoiu, M., Pădureanu, R., Radu, L. ... Pădureanu, V. (2022). Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes. Experimental and Therapeutic Medicine, 23, 73. https://doi.org/10.3892/etm.2021.10996
MLA
Vladu, I. M., Forțofoiu, M., Clenciu, D., Forțofoiu, M., Pădureanu, R., Radu, L., Cojan, Ș. T., Rădulescu, P. M., Pădureanu, V."Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes". Experimental and Therapeutic Medicine 23.1 (2022): 73.
Chicago
Vladu, I. M., Forțofoiu, M., Clenciu, D., Forțofoiu, M., Pădureanu, R., Radu, L., Cojan, Ș. T., Rădulescu, P. M., Pădureanu, V."Insulin resistance quantified by the value of HOMA‑IR and cardiovascular risk in patients with type 2 diabetes". Experimental and Therapeutic Medicine 23, no. 1 (2022): 73. https://doi.org/10.3892/etm.2021.10996
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team